Melanie Mestdagt is the founder of EyeD Pharma. EyeD Pharma has raised $108M in total funding. Latest round: Series A. Backed by Fund+, Qbic II, Gilles Samyn.
Mélanie Mestdagt is the CEO of EyeD Pharma, a Liège-based biotech company focused on micro-implants for medical eye conditions. She has guided the company through multiple funding rounds, including a €45 million raise in 2021 and a €28 million round in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library